← Back to Search

Procedure

Attune Cementless, Fixed Bearing, Cruciate Retaining TKA System for Osteoarthritis

N/A
Waitlist Available
Led By Thomas Turgeon, MD
Research Sponsored by Canadian Radiostereometric Analysis Network
Eligibility Criteria Checklist
Specific guidelines that determine who can or cannot participate in a clinical trial
Must have
Symptomatic osteoarthritis of the knee indicating primary total knee arthroplasty
Patients aged 21 years or older
Timeline
Screening 3 weeks
Treatment Varies
Follow Up 6-12 months, 1-2 years post-operative
Awards & highlights

Study Summary

This trial is studying patients who are having knee surgery using a specific type of knee replacement system called Attune Cementless, Fixed Bearing, Cruciate Retaining TKA System. The trial is being conducted

Who is the study for?
This trial is for individuals with osteoarthritis who are candidates for total knee replacement surgery. Specific eligibility criteria to participate in the study have not been provided, so interested patients should contact the study organizers for more information.Check my eligibility
What is being tested?
The trial is evaluating a specific type of knee replacement called the Attune Cementless, Fixed Bearing, Cruciate Retaining TKA System. It's being tested at multiple centers and involves patients receiving this particular implant during their surgery.See study design
What are the potential side effects?
Potential side effects are not detailed here but may include typical risks associated with knee replacement surgeries such as pain, swelling, infection risk at the surgical site, blood clots, or issues related to how well the implant fixes to bone.

Eligibility Criteria

Inclusion Criteria

You may be eligible if you check “Yes” for the criteria below
Select...
I need a knee replacement due to severe arthritis pain.
Select...
I am 21 years old or older.

Timeline

Screening ~ 3 weeks
Treatment ~ Varies
Follow Up ~6-12 months, 1-2 years post-operative
This trial's timeline: 3 weeks for screening, Varies for treatment, and 6-12 months, 1-2 years post-operative for reporting.

Treatment Details

Study Objectives

Outcome measures can provide a clearer picture of what you can expect from a treatment.
Primary outcome measures
Tibial baseplate stability
Secondary outcome measures
Equivalency between CT-RSA-measured migration and the gold-standard of RSA-measured migration
European Quality of Life (EQ-5D-5L)
Femoral component migration
+6 more

Trial Design

1Treatment groups
Experimental Treatment
Group I: Attune Cementless, Fixed Bearing, Cruciate Retaining TKA SystemExperimental Treatment1 Intervention
Attune Cruciate Retaining TKA System

Find a Location

Who is running the clinical trial?

Canadian Radiostereometric Analysis NetworkLead Sponsor
7 Previous Clinical Trials
365 Total Patients Enrolled
3 Trials studying Osteoarthritis
133 Patients Enrolled for Osteoarthritis
Thomas Turgeon, MDPrincipal InvestigatorConcordia Hospital
8 Previous Clinical Trials
351 Total Patients Enrolled
1 Trials studying Osteoarthritis
11 Patients Enrolled for Osteoarthritis

Frequently Asked Questions

These questions and answers are submitted by anonymous patients, and have not been verified by our internal team.

Are there any available vacancies for potential participants in this research study?

"Based on the information available on clinicaltrials.gov, it appears that this particular clinical trial is not currently seeking participants. The trial was initially posted on March 1st, 2024 and was last updated on December 19th, 2023. However, there are presently 647 alternative studies actively recruiting patients at this time."

Answered by AI
~20 spots leftby Dec 2026